Nothing Anemic About Ferahame: The Med Helps Amag Exceeds Street Expectations
This article was originally published in The Pink Sheet Daily
Executive Summary
With a broad label already in place, Amag plans to increase market for chronic kidney disease drug through label and geographic expansion.